nodes	percent_of_prediction	percent_of_DWPC	metapath
Aprepitant—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.444	1	CbGbCtD
Aprepitant—TACR1—cranial nerve—amyotrophic lateral sclerosis	0.0281	0.18	CbGeAlD
Aprepitant—TACR3—hindbrain—amyotrophic lateral sclerosis	0.0278	0.179	CbGeAlD
Aprepitant—White blood cell count increased—Riluzole—amyotrophic lateral sclerosis	0.0226	0.0596	CcSEcCtD
Aprepitant—TACR1—peripheral nervous system—amyotrophic lateral sclerosis	0.0185	0.119	CbGeAlD
Aprepitant—TACR3—brainstem—amyotrophic lateral sclerosis	0.016	0.102	CbGeAlD
Aprepitant—TACR1—nerve—amyotrophic lateral sclerosis	0.0144	0.0925	CbGeAlD
Aprepitant—White blood cell count decreased—Riluzole—amyotrophic lateral sclerosis	0.00913	0.024	CcSEcCtD
Aprepitant—TACR3—nervous system—amyotrophic lateral sclerosis	0.00836	0.0537	CbGeAlD
Aprepitant—Hypothermia—Riluzole—amyotrophic lateral sclerosis	0.0081	0.0213	CcSEcCtD
Aprepitant—Body temperature decreased—Riluzole—amyotrophic lateral sclerosis	0.0081	0.0213	CcSEcCtD
Aprepitant—TACR3—central nervous system—amyotrophic lateral sclerosis	0.00805	0.0517	CbGeAlD
Aprepitant—TACR3—cerebellum—amyotrophic lateral sclerosis	0.00787	0.0505	CbGeAlD
Aprepitant—Polyp—Riluzole—amyotrophic lateral sclerosis	0.00747	0.0197	CcSEcCtD
Aprepitant—Oral candidiasis—Riluzole—amyotrophic lateral sclerosis	0.00715	0.0188	CcSEcCtD
Aprepitant—Embolism—Riluzole—amyotrophic lateral sclerosis	0.00708	0.0186	CcSEcCtD
Aprepitant—Upset stomach—Riluzole—amyotrophic lateral sclerosis	0.00693	0.0182	CcSEcCtD
Aprepitant—Cyst—Riluzole—amyotrophic lateral sclerosis	0.0068	0.0179	CcSEcCtD
Aprepitant—Seborrhoeic dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00666	0.0175	CcSEcCtD
Aprepitant—Haemoglobin decreased—Riluzole—amyotrophic lateral sclerosis	0.0066	0.0174	CcSEcCtD
Aprepitant—TACR3—brain—amyotrophic lateral sclerosis	0.00639	0.041	CbGeAlD
Aprepitant—TACR1—brainstem—amyotrophic lateral sclerosis	0.00618	0.0397	CbGeAlD
Aprepitant—Pulmonary function test decreased—Riluzole—amyotrophic lateral sclerosis	0.00603	0.0159	CcSEcCtD
Aprepitant—Respiratory depression—Riluzole—amyotrophic lateral sclerosis	0.00603	0.0159	CcSEcCtD
Aprepitant—Glycosuria—Riluzole—amyotrophic lateral sclerosis	0.00561	0.0148	CcSEcCtD
Aprepitant—Blood bilirubin increased—Riluzole—amyotrophic lateral sclerosis	0.0048	0.0126	CcSEcCtD
Aprepitant—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.0048	0.0126	CcSEcCtD
Aprepitant—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.00465	0.0122	CcSEcCtD
Aprepitant—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.00463	0.0122	CcSEcCtD
Aprepitant—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.00454	0.012	CcSEcCtD
Aprepitant—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.00454	0.012	CcSEcCtD
Aprepitant—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.00454	0.012	CcSEcCtD
Aprepitant—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00439	0.0115	CcSEcCtD
Aprepitant—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.00434	0.0114	CcSEcCtD
Aprepitant—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.00411	0.0108	CcSEcCtD
Aprepitant—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.0039	0.0103	CcSEcCtD
Aprepitant—TACR1—spinal cord—amyotrophic lateral sclerosis	0.00384	0.0247	CbGeAlD
Aprepitant—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.00379	0.00998	CcSEcCtD
Aprepitant—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.00379	0.00998	CcSEcCtD
Aprepitant—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.00376	0.00988	CcSEcCtD
Aprepitant—Thirst—Riluzole—amyotrophic lateral sclerosis	0.00346	0.00912	CcSEcCtD
Aprepitant—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.00331	0.00871	CcSEcCtD
Aprepitant—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.0033	0.00868	CcSEcCtD
Aprepitant—TACR1—nervous system—amyotrophic lateral sclerosis	0.00324	0.0208	CbGeAlD
Aprepitant—TACR1—central nervous system—amyotrophic lateral sclerosis	0.00312	0.02	CbGeAlD
Aprepitant—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00307	0.00807	CcSEcCtD
Aprepitant—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.003	0.0079	CcSEcCtD
Aprepitant—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.00298	0.00784	CcSEcCtD
Aprepitant—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00297	0.00781	CcSEcCtD
Aprepitant—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00292	0.00768	CcSEcCtD
Aprepitant—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00291	0.00765	CcSEcCtD
Aprepitant—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00291	0.00765	CcSEcCtD
Aprepitant—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00287	0.00755	CcSEcCtD
Aprepitant—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00285	0.0075	CcSEcCtD
Aprepitant—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00273	0.00719	CcSEcCtD
Aprepitant—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00267	0.00701	CcSEcCtD
Aprepitant—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00267	0.00701	CcSEcCtD
Aprepitant—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00263	0.00693	CcSEcCtD
Aprepitant—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.0026	0.00685	CcSEcCtD
Aprepitant—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00259	0.00683	CcSEcCtD
Aprepitant—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00258	0.00679	CcSEcCtD
Aprepitant—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00256	0.00673	CcSEcCtD
Aprepitant—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00254	0.00669	CcSEcCtD
Aprepitant—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00254	0.00669	CcSEcCtD
Aprepitant—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00251	0.00659	CcSEcCtD
Aprepitant—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00249	0.00656	CcSEcCtD
Aprepitant—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00249	0.00656	CcSEcCtD
Aprepitant—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00248	0.00652	CcSEcCtD
Aprepitant—TACR1—brain—amyotrophic lateral sclerosis	0.00247	0.0159	CbGeAlD
Aprepitant—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00247	0.0065	CcSEcCtD
Aprepitant—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00242	0.00638	CcSEcCtD
Aprepitant—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00232	0.00611	CcSEcCtD
Aprepitant—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00227	0.00597	CcSEcCtD
Aprepitant—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00227	0.00597	CcSEcCtD
Aprepitant—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00226	0.00596	CcSEcCtD
Aprepitant—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00225	0.00593	CcSEcCtD
Aprepitant—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00224	0.0059	CcSEcCtD
Aprepitant—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00224	0.00588	CcSEcCtD
Aprepitant—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00216	0.00568	CcSEcCtD
Aprepitant—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00213	0.00561	CcSEcCtD
Aprepitant—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00212	0.00557	CcSEcCtD
Aprepitant—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00207	0.00545	CcSEcCtD
Aprepitant—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00206	0.00542	CcSEcCtD
Aprepitant—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00206	0.00541	CcSEcCtD
Aprepitant—Chills—Riluzole—amyotrophic lateral sclerosis	0.00205	0.00539	CcSEcCtD
Aprepitant—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00202	0.0053	CcSEcCtD
Aprepitant—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.002	0.00526	CcSEcCtD
Aprepitant—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00199	0.00523	CcSEcCtD
Aprepitant—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00196	0.00515	CcSEcCtD
Aprepitant—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00194	0.00512	CcSEcCtD
Aprepitant—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00192	0.00506	CcSEcCtD
Aprepitant—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00191	0.00502	CcSEcCtD
Aprepitant—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00186	0.0049	CcSEcCtD
Aprepitant—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00184	0.00485	CcSEcCtD
Aprepitant—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00184	0.00483	CcSEcCtD
Aprepitant—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00181	0.00478	CcSEcCtD
Aprepitant—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00471	CcSEcCtD
Aprepitant—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00178	0.00469	CcSEcCtD
Aprepitant—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00175	0.00462	CcSEcCtD
Aprepitant—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00175	0.00459	CcSEcCtD
Aprepitant—Cough—Riluzole—amyotrophic lateral sclerosis	0.00173	0.00456	CcSEcCtD
Aprepitant—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00172	0.00453	CcSEcCtD
Aprepitant—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00171	0.00451	CcSEcCtD
Aprepitant—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00169	0.00445	CcSEcCtD
Aprepitant—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00169	0.00445	CcSEcCtD
Aprepitant—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00169	0.00445	CcSEcCtD
Aprepitant—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00168	0.00443	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00168	0.00442	CcSEcCtD
Aprepitant—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00167	0.0044	CcSEcCtD
Aprepitant—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00165	0.00435	CcSEcCtD
Aprepitant—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00163	0.0043	CcSEcCtD
Aprepitant—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00162	0.00427	CcSEcCtD
Aprepitant—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00162	0.00427	CcSEcCtD
Aprepitant—Infection—Riluzole—amyotrophic lateral sclerosis	0.00161	0.00424	CcSEcCtD
Aprepitant—Shock—Riluzole—amyotrophic lateral sclerosis	0.00159	0.0042	CcSEcCtD
Aprepitant—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00159	0.00418	CcSEcCtD
Aprepitant—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00159	0.00418	CcSEcCtD
Aprepitant—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00158	0.00416	CcSEcCtD
Aprepitant—TACR1—Spinal Cord Injury—PTPRZ1—amyotrophic lateral sclerosis	0.00158	0.0762	CbGpPWpGaD
Aprepitant—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00157	0.00414	CcSEcCtD
Aprepitant—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00157	0.00412	CcSEcCtD
Aprepitant—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00154	0.00407	CcSEcCtD
Aprepitant—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00151	0.00399	CcSEcCtD
Aprepitant—TACR3—Peptide GPCRs—C5AR1—amyotrophic lateral sclerosis	0.00148	0.0713	CbGpPWpGaD
Aprepitant—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00148	0.00389	CcSEcCtD
Aprepitant—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00147	0.00386	CcSEcCtD
Aprepitant—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00146	0.00383	CcSEcCtD
Aprepitant—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00144	0.0038	CcSEcCtD
Aprepitant—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00144	0.00379	CcSEcCtD
Aprepitant—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00143	0.00375	CcSEcCtD
Aprepitant—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00141	0.00371	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.0014	0.00368	CcSEcCtD
Aprepitant—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.0014	0.00368	CcSEcCtD
Aprepitant—Pain—Riluzole—amyotrophic lateral sclerosis	0.00139	0.00365	CcSEcCtD
Aprepitant—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00139	0.00365	CcSEcCtD
Aprepitant—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00134	0.00351	CcSEcCtD
Aprepitant—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00133	0.00349	CcSEcCtD
Aprepitant—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00339	CcSEcCtD
Aprepitant—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00128	0.00337	CcSEcCtD
Aprepitant—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00128	0.00337	CcSEcCtD
Aprepitant—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00119	0.00314	CcSEcCtD
Aprepitant—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00116	0.00306	CcSEcCtD
Aprepitant—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00302	CcSEcCtD
Aprepitant—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00292	CcSEcCtD
Aprepitant—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00282	CcSEcCtD
Aprepitant—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00271	CcSEcCtD
Aprepitant—Rash—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00269	CcSEcCtD
Aprepitant—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00269	CcSEcCtD
Aprepitant—Headache—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00267	CcSEcCtD
Aprepitant—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000963	0.00253	CcSEcCtD
Aprepitant—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000731	0.00469	CbGeAlD
Aprepitant—TACR1—Peptide GPCRs—C5AR1—amyotrophic lateral sclerosis	0.000721	0.0348	CbGpPWpGaD
Aprepitant—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000704	0.00452	CbGeAlD
Aprepitant—TACR3—Peptide ligand-binding receptors—C5AR1—amyotrophic lateral sclerosis	0.000695	0.0335	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.000616	0.0298	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—RTN4—amyotrophic lateral sclerosis	0.000616	0.0297	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—GFAP—amyotrophic lateral sclerosis	0.000502	0.0242	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—AQP4—amyotrophic lateral sclerosis	0.000497	0.024	CbGpPWpGaD
Aprepitant—CYP2C19—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.000475	0.0229	CbGpPWpGaD
Aprepitant—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—amyotrophic lateral sclerosis	0.000468	0.0226	CbGpPWpGaD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.000466	0.0225	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.000397	0.0192	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.000397	0.0192	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.000397	0.0192	CbGpPWpGaD
Aprepitant—CYP1A2—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.00037	0.0179	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.000355	0.0171	CbGpPWpGaD
Aprepitant—TACR1—Peptide ligand-binding receptors—C5AR1—amyotrophic lateral sclerosis	0.000339	0.0164	CbGpPWpGaD
Aprepitant—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000311	0.015	CbGpPWpGaD
Aprepitant—TACR3—Peptide ligand-binding receptors—C3—amyotrophic lateral sclerosis	0.000303	0.0146	CbGpPWpGaD
Aprepitant—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000266	0.0128	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—BDNF—amyotrophic lateral sclerosis	0.000257	0.0124	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.000228	0.011	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000205	0.00992	CbGpPWpGaD
Aprepitant—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000205	0.0099	CbGpPWpGaD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000203	0.00982	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.0002	0.00968	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000182	0.00879	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.000173	0.00836	CbGpPWpGaD
Aprepitant—CYP3A7—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000158	0.00765	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000155	0.00748	CbGpPWpGaD
Aprepitant—TACR1—Peptide ligand-binding receptors—C3—amyotrophic lateral sclerosis	0.000148	0.00715	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000142	0.00685	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—PTGS2—amyotrophic lateral sclerosis	0.000138	0.00667	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000133	0.00644	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—CASP3—amyotrophic lateral sclerosis	0.000128	0.0062	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000126	0.00611	CbGpPWpGaD
Aprepitant—CYP2C19—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.000124	0.00601	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000122	0.00591	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—MMP9—amyotrophic lateral sclerosis	0.000121	0.00586	CbGpPWpGaD
Aprepitant—CYP3A5—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000114	0.00553	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000109	0.00525	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000108	0.00519	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000103	0.00496	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	9.93e-05	0.00479	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	9.79e-05	0.00473	CbGpPWpGaD
Aprepitant—CYP2C19—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.78e-05	0.00472	CbGpPWpGaD
Aprepitant—CYP1A2—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	9.69e-05	0.00468	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	8.99e-05	0.00434	CbGpPWpGaD
Aprepitant—CYP2C9—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.92e-05	0.0043	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	8.89e-05	0.00429	CbGpPWpGaD
Aprepitant—CYP2C19—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	8.85e-05	0.00427	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	8.75e-05	0.00422	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	8.71e-05	0.00421	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	8.23e-05	0.00397	CbGpPWpGaD
Aprepitant—CYP2C9—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	8.07e-05	0.0039	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—C3—amyotrophic lateral sclerosis	7.95e-05	0.00384	CbGpPWpGaD
Aprepitant—CYP1A2—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.62e-05	0.00368	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—C3—amyotrophic lateral sclerosis	7.56e-05	0.00365	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	7.39e-05	0.00357	CbGpPWpGaD
Aprepitant—CYP3A7—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	7.09e-05	0.00342	CbGpPWpGaD
Aprepitant—CYP3A7—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	6.99e-05	0.00337	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	6.93e-05	0.00335	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	6.93e-05	0.00335	CbGpPWpGaD
Aprepitant—CYP1A2—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	6.9e-05	0.00333	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	6.81e-05	0.00329	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	6.6e-05	0.00319	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	6.52e-05	0.00315	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	6.23e-05	0.00301	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	6.21e-05	0.003	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	6.18e-05	0.00298	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	5.98e-05	0.00289	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	5.79e-05	0.0028	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	5.68e-05	0.00274	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	5.65e-05	0.00273	CbGpPWpGaD
Aprepitant—CYP2C19—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	5.51e-05	0.00266	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	5.45e-05	0.00263	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—TPK1—amyotrophic lateral sclerosis	5.43e-05	0.00262	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—VAPB—amyotrophic lateral sclerosis	5.43e-05	0.00262	CbGpPWpGaD
Aprepitant—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	5.32e-05	0.00257	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	5.31e-05	0.00256	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	5.31e-05	0.00256	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	5.31e-05	0.00256	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	5.28e-05	0.00255	CbGpPWpGaD
Aprepitant—CYP1A2—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	5.27e-05	0.00255	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	5.25e-05	0.00254	CbGpPWpGaD
Aprepitant—CYP3A5—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	5.12e-05	0.00247	CbGpPWpGaD
Aprepitant—CYP3A5—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	5.05e-05	0.00244	CbGpPWpGaD
Aprepitant—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	5.03e-05	0.00243	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	4.97e-05	0.0024	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—VAPA—amyotrophic lateral sclerosis	4.97e-05	0.0024	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	4.86e-05	0.00234	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—C3—amyotrophic lateral sclerosis	4.69e-05	0.00227	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.62e-05	0.00223	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	4.59e-05	0.00222	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	4.51e-05	0.00218	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	4.39e-05	0.00212	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.37e-05	0.00211	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—FIG4—amyotrophic lateral sclerosis	4.34e-05	0.0021	CbGpPWpGaD
Aprepitant—CYP1A2—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	4.3e-05	0.00207	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	4.27e-05	0.00206	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	4.24e-05	0.00205	CbGpPWpGaD
Aprepitant—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.96e-05	0.00191	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—DAO—amyotrophic lateral sclerosis	3.93e-05	0.0019	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—TPK1—amyotrophic lateral sclerosis	3.93e-05	0.0019	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—VAPB—amyotrophic lateral sclerosis	3.93e-05	0.0019	CbGpPWpGaD
Aprepitant—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.91e-05	0.00189	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	3.88e-05	0.00187	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	3.73e-05	0.0018	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	3.62e-05	0.00175	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.61e-05	0.00174	CbGpPWpGaD
Aprepitant—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.61e-05	0.00174	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	3.61e-05	0.00174	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—VAPA—amyotrophic lateral sclerosis	3.59e-05	0.00173	CbGpPWpGaD
Aprepitant—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.56e-05	0.00172	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	3.4e-05	0.00164	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.38e-05	0.00163	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.34e-05	0.00161	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.22e-05	0.00156	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—FIG4—amyotrophic lateral sclerosis	3.14e-05	0.00152	CbGpPWpGaD
Aprepitant—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.09e-05	0.00149	CbGpPWpGaD
Aprepitant—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.04e-05	0.00147	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	3.03e-05	0.00147	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	3.03e-05	0.00147	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PLB1—amyotrophic lateral sclerosis	2.98e-05	0.00144	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.91e-05	0.0014	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—DAO—amyotrophic lateral sclerosis	2.84e-05	0.00137	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.83e-05	0.00137	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.78e-05	0.00134	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	2.78e-05	0.00134	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	2.77e-05	0.00134	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	2.77e-05	0.00134	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.76e-05	0.00133	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—GSR—amyotrophic lateral sclerosis	2.75e-05	0.00133	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.63e-05	0.00127	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.59e-05	0.00125	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.58e-05	0.00125	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.58e-05	0.00125	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	2.53e-05	0.00122	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	2.43e-05	0.00117	CbGpPWpGaD
Aprepitant—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.38e-05	0.00115	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	2.36e-05	0.00114	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	2.36e-05	0.00114	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.36e-05	0.00114	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.35e-05	0.00114	CbGpPWpGaD
Aprepitant—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.35e-05	0.00113	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.29e-05	0.00111	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CHAT—amyotrophic lateral sclerosis	2.25e-05	0.00109	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	2.21e-05	0.00107	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.2e-05	0.00106	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	2.19e-05	0.00106	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	2.16e-05	0.00104	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PLB1—amyotrophic lateral sclerosis	2.15e-05	0.00104	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.13e-05	0.00103	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.01e-05	0.000971	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	2e-05	0.000966	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GSR—amyotrophic lateral sclerosis	1.98e-05	0.000958	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	1.89e-05	0.000913	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	1.82e-05	0.000881	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	1.82e-05	0.000881	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.78e-05	0.00086	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.76e-05	0.000851	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	1.71e-05	0.000825	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	1.67e-05	0.000806	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	1.66e-05	0.000803	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CHAT—amyotrophic lateral sclerosis	1.63e-05	0.000787	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.55e-05	0.000749	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	1.53e-05	0.000741	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	1.52e-05	0.000732	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	1.46e-05	0.000704	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	1.4e-05	0.000676	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.4e-05	0.000675	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.36e-05	0.000655	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	1.32e-05	0.000637	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	1.3e-05	0.000626	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.28e-05	0.000619	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.27e-05	0.000615	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	1.26e-05	0.000608	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.21e-05	0.000585	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	1.2e-05	0.000577	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.15e-05	0.000556	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.15e-05	0.000555	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	1.15e-05	0.000555	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.11e-05	0.000538	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.09e-05	0.000526	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.05e-05	0.000506	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	1e-05	0.000483	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	9.82e-06	0.000474	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	9.23e-06	0.000446	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—APOE—amyotrophic lateral sclerosis	9.16e-06	0.000442	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	8.96e-06	0.000433	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.76e-06	0.000423	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	8.7e-06	0.00042	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.05e-06	0.000389	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	7.88e-06	0.00038	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	7.58e-06	0.000366	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	7.18e-06	0.000347	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.77e-06	0.000327	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	6.62e-06	0.00032	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.28e-06	0.000303	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.22e-06	0.0003	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.18e-06	0.000298	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.14e-06	0.000296	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.68e-06	0.000274	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.28e-06	0.000255	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	5.12e-06	0.000247	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.85e-06	0.000234	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	4.67e-06	0.000225	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.54e-06	0.000219	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.07e-06	0.000197	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	3.99e-06	0.000193	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.74e-06	0.000181	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.51e-06	0.000169	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.2e-06	0.000154	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	3.08e-06	0.000149	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.73e-06	0.000132	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.11e-06	0.000102	CbGpPWpGaD
